CONMED Corp. (CNMD)
49.32
-0.10
(-0.20%)
USD |
NYSE |
Sep 04, 16:00
49.32
0.00 (0.00%)
After-Hours: 20:00
CONMED Research and Development Expense (Quarterly) : 15.50M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.50M |
| March 31, 2026 | 16.33M |
| December 31, 2025 | 14.90M |
| September 30, 2025 | 13.90M |
| June 30, 2025 | 14.14M |
| March 31, 2025 | 12.95M |
| December 31, 2024 | 13.18M |
| September 30, 2024 | 13.56M |
| June 30, 2024 | 14.10M |
| March 31, 2024 | 13.59M |
| December 31, 2023 | 14.03M |
| September 30, 2023 | 12.46M |
| June 30, 2023 | 13.57M |
| March 31, 2023 | 12.54M |
| December 31, 2022 | 12.22M |
| September 30, 2022 | 12.77M |
| June 30, 2022 | 11.49M |
| March 31, 2022 | 10.67M |
| December 31, 2021 | 11.36M |
| September 30, 2021 | 10.86M |
| June 30, 2021 | 11.32M |
| March 31, 2021 | 10.03M |
| December 31, 2020 | 11.72M |
| September 30, 2020 | 9.936M |
| June 30, 2020 | 8.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.12M |
| December 31, 2019 | 12.09M |
| September 30, 2019 | 10.98M |
| June 30, 2019 | 11.81M |
| March 31, 2019 | 10.58M |
| December 31, 2018 | 10.37M |
| September 30, 2018 | 4.622M |
| June 30, 2018 | 9.985M |
| March 31, 2018 | 7.711M |
| December 31, 2017 | 8.378M |
| September 30, 2017 | 8.27M |
| June 30, 2017 | 8.041M |
| March 31, 2017 | 7.618M |
| December 31, 2016 | 7.634M |
| September 30, 2016 | 8.353M |
| June 30, 2016 | 8.009M |
| March 31, 2016 | 8.258M |
| December 31, 2015 | 6.741M |
| September 30, 2015 | 6.652M |
| June 30, 2015 | 7.501M |
| March 31, 2015 | 6.542M |
| December 31, 2014 | 7.105M |
| September 30, 2014 | 6.91M |
| June 30, 2014 | 6.854M |
| March 31, 2014 | 6.91M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp. | 424.00M |
| Globus Medical, Inc. | 36.32M |
| Alphatec Holdings, Inc. | 18.17M |
| Baxter International, Inc. | 125.00M |
| Becton, Dickinson & Co. | 258.00M |